Optimising recruitment to a late-phase tuberculosis clinical trial: a qualitative study exploring patient and practitioner experiences in Uzbekistan
Abstract Background Addressing the global burden of multidrug-resistant tuberculosis (MDR-TB) requires identification of shorter, less toxic treatment regimens. Médecins Sans Frontières (MSF) is currently conducting a phase II/III randomised controlled clinical trial, to find more effective, shorter...
Guardado en:
Autores principales: | Alexandra Wharton-Smith, Shona Horter, Emma Douch, Nell Gray, Nicola James, Bern-Thomas Nyang’wa, Jatinder Singh, Parpieva Nargiza Nusratovna, Zinaida Tigay, Emil Kazounis, Gulayim Allanazarova, Beverley Stringer |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e2fede73cd4149599b0eaf002feba403 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeting Drug-Sensitive and -Resistant Strains of <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> by Inhibition of Src Family Kinases Lowers Disease Burden and Pathology
por: Pallavi Chandra, et al.
Publicado: (2016) -
High rate of successful treatment outcomes among childhood rifampicin/multidrug-resistant tuberculosis in Pakistan: a multicentre retrospective observational analysis
por: Farah Naz, et al.
Publicado: (2021) -
Alginate-Capped Silver Nanoparticles as a Potent Anti-mycobacterial Agent Against Mycobacterium tuberculosis
por: Cheng-Cheung Chen, et al.
Publicado: (2021) -
Detección de la mutación S315T en el gen katg como estrategia para identificación de Mycobacterium tuberculosis resistente a isoniacida en un laboratorio de referencia
por: Romay,Zolay, et al.
Publicado: (2012) -
The effects of acceptance and commitment therapy on psychosocial impact and adherence of MDR-TB patients
por: Priyo Purnomo As’hab, et al.
Publicado: (2021)